Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2023-07-04 2019-12-05
Drug Identification Number 02305062 02305062
Brand name APO-METFORMIN ER APO-METFORMIN ER
Common or Proper name METFORMIN METFORMIN
Company Name APOTEX INC APOTEX INC
Ingredients METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code A10BA A10BA
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-02 2019-12-02
Estimated end date Unknown Unknown
Actual end date 2023-06-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments